Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 27,796 |
|
|||||
| News | - | ||||||
| Day High | 2.00 | Low High |
|||||
| Day Low | 1.95 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Palatin Technologies Inc New | PTN | AMEX | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.04 | 2.04% | 2.00 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.99 | 1.95 | 2.00 | 2.00 | 1.96 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 265 | 27,796 | $ 1.98 | $ 54,941 | - | 1.43 - 5.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 20:00:00 | 514 | $ 2.00 | USD |
Palatin Technologies Inc New Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 27.47M | 13.74M | - | 5.88M | -27.54M | -2.00 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Palatin Technologies News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PTN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.00 | 2.05 | 1.86 | 1.95 | 61,607 | 0.00 | 0.0% |
| 1 Month | 2.11 | 2.2778 | 1.81 | 1.99 | 67,761 | -0.11 | -5.21% |
| 3 Months | 2.29 | 2.60 | 1.43 | 1.95 | 121,343 | -0.29 | -12.66% |
| 6 Months | 2.55 | 3.27 | 1.43 | 2.13 | 96,870 | -0.55 | -21.57% |
| 1 Year | 3.78 | 5.00 | 1.43 | 2.51 | 86,436 | -1.78 | -47.09% |
| 3 Years | 0.45 | 8.60 | 0.1811 | 0.7249662 | 1,942,134 | 1.55 | 344.44% |
| 5 Years | 0.81 | 8.60 | 0.1811 | 0.7646353 | 1,842,883 | 1.19 | 146.91% |
Palatin Technologies Description
| Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its main product in clinical development is bremelanotide, which treats hypoactive sexual desire disorder, which is a type of female sexual dysfunction. |
